interferon-alpha (Alkermes)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameinterferon-alpha (Alkermes)
Drug Alias NameProLease Intron A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon alpha modulators
TargetsInterferon alpha
Therapy Area/IndicationsNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkermes PlcSchering-Plough Corp
Active IndicationsN/A
Inactive IndicationsNeoplasmsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A